3rd Edition of Dementia World Conference DWC 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 3rd Edition of Dementia World Conference DWC 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
3rd Edition of Dementia World Conference (DWC 2026)
Dates: November 10–12, 2026
Venue: Village Hotel Changi, Singapore
Contact: +1-571-5561014 | dementia@precisionglobalconferences.com
Event Format: Hybrid (In-Person & Virtual)
About the Conference
Organized by Precision Global Conferences, the 3rd Edition of Dementia World Conference (DWC 2026) brings together global experts in Alzheimer’s disease, brain disorders, and neurodegenerative conditions. Themed "Rediscovering Memory, Transforming Health", this event serves as a dynamic platform for professionals to connect, share research, and address the complex challenges of dementia care.
The conference emphasizes the latest breakthroughs in dementia research, treatment advancements, and holistic care strategies. Attendees will explore topics spanning Alzheimer’s disease, vascular dementia, Parkinson’s disease, neuropharmacology, and stages of dementia progression. The event’s vision is to push the boundaries of knowledge while fostering collaboration among researchers, clinicians, caregivers, and policymakers.
Key Highlights
- Scientific Sessions:
- Dementia & Brain Aging
- Alzheimer’s Disease Mechanisms
- Vascular & Mixed Dementia
- Neurodegenerative Diseases
- Neuropharmacology Innovations
- Target Audience: Neurologists, psychiatrists, geriatricians, researchers, caregivers, healthcare policymakers, and dementia advocacy groups.
- Networking Opportunities: Connect with 100+ visitors, including leading scientists, industry partners, and patient advocates through in-person and virtual formats.
- Hybrid Participation: Attend sessions live at Village Hotel Changi, Singapore, or join virtually from anywhere in the world.
Committee & Featured Speakers
Organizing Committee
- Nian Wang - Advanced Imaging Research Center
- Ailin Liu - Institute of Materia Medica, Chinese Academy of Medical Sciences
- Osman Kucuk - President, Organizing Committee of iCoDem
- Shouzi Zhang - Chief Physician, Beijing Geriatric Hospital See full committee here.
Featured Speakers
- Rachel MacLean - University of New Brunswick
- Laszlo Varga - Netis Informatics Ltd
- Megan Kirk Chang - University of Oxford
- Prabhakar Tiwari - All India Institute of Medical Sciences View full speaker lineup here.
Why Attend DWC 2026?
- Present cutting-edge research to a global audience.
- Network with pioneers in dementia care and research.
- Access updates on diagnostic tools, therapeutic advancements, and care strategies.
- Enhance career opportunities through collaborations and partnerships.
Registration & Deadlines
Early Bird Registration: Ends on 30 June 2026
Abstract Submissions: Ends on 25 June 2026
Register Now | Download Brochure
Sponsors & Partners
DWC 2026 is supported by leading organizations in healthcare, research, and pharmaceutical industries. Partner with us to showcase innovations in dementia care and diagnostics. Become a Sponsor
Venue & Hospitality
Village Hotel Changi
50 Sungei Ibise Lane, Singapore 508872
Discover tranquil accommodations and modern facilities in one of Singapore’s premier hotels, ideal for networking and relaxation.
Data sheet
3rd Edition of Dementia World Conference DWC 2026 – Event Attendee & Buyer Profile Analysis
Event Date: November 10–12, 2026
Location: Village Hotel Changi, Singapore, Singapore
Event Status: Upcoming
Research Date: June 30, 2026
Event Overview
| Event Name | 3rd Edition of Dementia World Conference DWC 2026 |
| Event Date | November 10–12, 2026 |
| Event Status | Upcoming |
| Venue | Village Hotel Changi |
| City | Singapore |
| State / Region | Singapore |
| Country | Singapore |
| Organizer | Precision Global Conferences |
| Official Event Website | dementiaworldconference.com |
| Event Type | Hybrid conference |
| Primary Category | Wellness, Health & Fitness |
| Secondary Applicable Categories | Medical & Pharma; Science & Research |
| Audience Reach | Global scientific and clinical audience |
| Estimated Attendance / Expected Footfall | 100+ visitors (official site statement) |
| Attendance Data Reliability | Confirmed from official event website; detailed attendee breakdown not publicly confirmed by the organizer. |
| Main Purpose of Event | To convene global experts in dementia, Alzheimer’s disease, Parkinson’s disease, and related neurodegenerative disorders for scientific exchange, care advancement, and collaboration. |
About the Event
The 3rd Edition of Dementia World Conference DWC 2026 is a hybrid international conference focused on dementia, Alzheimer’s disease, Parkinson’s disease, and related neurodegenerative conditions. Hosted in Singapore by Precision Global Conferences, the event brings together clinicians, researchers, academic contributors, and care-focused professionals around the theme “Rediscovering Memory, Transforming Health.”
This conference is relevant to organizations involved in neurological care, pharmaceutical research, diagnostics, aged-care innovation, and public-health policy. It offers a business and knowledge-sharing platform for stakeholders seeking scientific updates, collaboration opportunities, professional networking, and exposure to emerging care models and therapies in the dementia ecosystem.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical decision-makers | Hospitals, memory clinics, neurology departments, geriatric care centers | Evaluate therapies, diagnostic tools, care models, and clinical solutions | High-value audience for clinical, diagnostic, and patient-care offerings |
| Researchers and principal investigators | Universities, research institutes, medical schools, neuroscience centers | Influence study design, publication pathways, and technology adoption | Relevant for lab tools, biomarkers, data platforms, and research services |
| Pharma and biotech professionals | Pharmaceutical companies, biotech firms, CROs, drug development teams | Assess pipelines, partnerships, trial support, and market insight | Strong fit for trial services, analytics, biomarkers, and compliance support |
| Government and public-health stakeholders | Health ministries, public hospitals, aging-policy bodies, public agencies | Shape policy, funding, and care delivery frameworks | Relevant for population-health programs, training, and digital care initiatives |
| Care providers and long-term care operators | Nursing homes, assisted living operators, home-care providers | Buy care-management solutions, training, monitoring tools, and services | Highly relevant for care delivery technology and workforce training |
| Association leaders and advocacy groups | Dementia associations, Alzheimer’s foundations, caregiver networks | Influence education, awareness, and sponsorship decisions | Useful for partnerships, sponsorships, education, and outreach programs |
| Technology and digital-health leaders | Health-tech firms, telehealth providers, digital therapeutics teams | Assess software, data, AI, remote monitoring, and workflow tools | Relevant for digital diagnostics, remote care, and analytics vendors |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Singapore | Local hospitals, universities, healthcare networks, medical professionals | High | Singapore is a regional healthcare and research hub with strong conference accessibility. |
| Host country: Singapore | National healthcare institutions, public agencies, academic centers | High | Likely participation from national hospitals, research bodies, and government-linked entities. |
| Nearby business hubs | Malaysia, Indonesia, Thailand, Philippines, Hong Kong, India, Australia | Medium to High | Regional healthcare and research travel is plausible for a Singapore-based hybrid conference. |
| National reach | Singapore-based decision-makers and clinicians | High | Strong probability of local registration due to venue location and hybrid format. |
| International reach | Global researchers, clinicians, and dementia-care stakeholders | Medium to High | The event’s scientific theme and hybrid format support cross-border participation. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The conference markets to international experts in dementia, Alzheimer’s disease, Parkinson’s disease, and neurodegenerative research, with a hybrid participation option supporting global reach. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| National Neuroscience Institute | Healthcare organization | Neurology and dementia care stakeholders in Singapore | nni.com.sg | Director of Neurology, Clinical Research Lead, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| A*STAR | Research institution | Biomedical and neuroscience research relevance | astar.edu.sg | Research Director, Principal Investigator, Lab Operations Manager | Strong Market Fit, Attendance Not Confirmed |
| National University Hospital | Hospital / clinical buyer | Large care delivery organization with geriatric and neurology needs | nuh.com.sg | Head of Neurology, Facilities Director, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Singapore General Hospital | Hospital / clinical buyer | Potential buyer of clinical, diagnostic, and care-management solutions | sgh.com.sg | Clinical Director, Biomedical Manager, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| National Health Group | Healthcare system | System-level buyer for dementia care pathways and training | nhg.com.sg | Group Procurement Head, Program Director, Care Integration Lead | Strong Market Fit, Attendance Not Confirmed |
| Duke-NUS Medical School | Academic / research institution | Academic neuroscience, clinical research, and translational medicine | duke-nus.edu.sg | Professor, Research Fellow, Clinical Trials Manager | Strong Market Fit, Attendance Not Confirmed |
| Alzheimer’s Disease Association (Singapore) | Advocacy / nonprofit | Direct dementia advocacy, caregiver support, and outreach relevance | ada.org.sg | Executive Director, Partnerships Manager, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Agency for Integrated Care | Public-sector care organization | Care coordination and aging-services relevance | aic.sg | Director, Procurement Lead, Care Programs Head | Strong Market Fit, Attendance Not Confirmed |
| Parkway Pantai | Private healthcare operator | Hospital operator with geriatric and neurology care pathways | parkwaypantai.com | Operations Director, Clinical Director, Purchasing Manager | Strong Market Fit, Attendance Not Confirmed |
| KK Women’s and Children’s Hospital | Hospital / healthcare system | Relevant for clinical education, diagnostics, and care coordination | kkh.com.sg | Medical Director, Department Head, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Tan Tock Seng Hospital | Hospital / clinical buyer | Large public hospital with geriatrics and neurology interfaces | ttsh.com.sg | Clinical Lead, Nursing Director, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Medical Director | Clinical Leadership | C-Level / Executive | Influences adoption of clinical programs, diagnostics, and treatment pathways. |
| 2 | Director of Neurology / Geriatrics | Clinical Services | Director | Directly responsible for dementia and neurodegenerative care delivery. |
| 3 | Research Director / Principal Investigator | Research & Development | Director / Senior Researcher | Key decision-maker for research collaborations, tools, and funding priorities. |
| 4 | Clinical Trials Manager | Clinical Operations | Manager | Responsible for study execution, vendor coordination, and research tools. |
| 5 | Head of Procurement / Purchasing Manager | Procurement | Director / Manager | Purchases devices, software, services, and care infrastructure. |
| 6 | Operations Director | Operations | Director | Influences service delivery, workflow optimization, and digital solutions. |
| 7 | Program Manager / Care Program Lead | Program Management | Manager / Senior Manager | Manages dementia initiatives, pilots, and implementation projects. |
| 8 | Partnerships Director | Business Development / Partnerships | Director | Useful for sponsorships, collaborations, and joint programs. |
| 9 | CIO / IT Director / Digital Health Lead | Information Technology | Executive / Director | Evaluates digital care, analytics, telehealth, and workflow technology. |
| 10 | Policy Lead / Public Health Manager | Government / Public Health | Manager / Director | Relevant for funding, policy, and population-health implementation. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base for dementia and neurological care | Hospitals, clinics, long-term care buyers |
| 2 | Pharmaceuticals | Drug development and treatment innovation | Clinical research, pipeline partnership outreach |
| 3 | Biotechnology | Research-heavy audience and biomarker relevance | R&D collaborations, diagnostics, trials |
| 4 | Research | Scientific conference with strong research orientation | Institutes, labs, translational medicine teams |
| 5 | Medical Devices | Diagnostics, monitoring, and care-support technology | Device procurement and clinical evaluation |
| 6 | Information Technology & Services | Digital health, data, and workflow solutions | Telehealth, AI, analytics, EMR integrations |
| 7 | Government Administration | Policy and public-health relevance | Ministries, agencies, public buyers |
| 8 | Nonprofit Organization Management | Advocacy and caregiver support organizations | Partnerships, funding, awareness campaigns |
| 9 | Health, Wellness & Fitness | Care delivery and patient-support relevance | Behavioral health, wellness, prevention offerings |
| 10 | Higher Education | Academic participation is likely for this conference | Faculty, research, and training outreach |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 100+ visitors | Confirmed on official site | Official website homepage text | No larger attendance figure was publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Unavailable | Official website did not publish a verified count in the provided content | Sponsors/exhibitors page exists, but no numeric count was confirmed in source text. |
| Buyer count | Not publicly confirmed | Unavailable | No official buyer list published in the provided source text | Use attendee profiling rather than confirmed buyer counts. |
| Speaker count | At least 8 featured speakers shown | Confirmed on official site | Featured speakers section | Speaker list is partial, not necessarily complete. |
| Sponsor count | Not publicly confirmed | Unavailable | Official site references sponsors/exhibitors without a verified count in the provided content | No confirmed sponsor roster captured in source text. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Dementia care innovation | Improved care models, patient support, and clinical outcomes | Position solutions for clinical transformation and care quality | Care pathways, training, monitoring, patient-support tools |
| Alzheimer’s research | Biomarkers, trial support, and translational research | Engage research leaders with data-driven and lab-based solutions | Research services, assays, lab tools, analytics platforms |
| Neurodegenerative disorders | Cross-disease expertise and treatment insights | Broaden outreach to neurology, geriatrics, and pharma buyers | Clinical solutions, education programs, and drug-development services |
| Neuropharmacology | Therapeutic research and medication management | Connect with R&D, medical affairs, and clinical development teams | Pharma services, trial management, advisory support |
| Aging and geriatric care | Care coordination, facility management, and patient safety | Target long-term care operators and hospital administrators | Operations software, staffing support, care equipment |
| Digital health and remote care | Remote monitoring, telehealth, and workflow efficiency | Engage IT and operations leaders seeking scalable care tech | Telehealth, software, dashboards, AI-enabled tools |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event is directly centered on dementia care, research, and neurodegenerative disease stakeholders. |
| Decision-maker availability | High | Likely attendance from clinicians, researchers, healthcare managers, and advocacy leaders. |
| Data collection potential | Medium | Official site confirms the event, but current-year attendee and exhibitor lists were not publicly detailed in the provided content. |
| Apollo targeting potential | High | Strong targeting fit for healthcare, pharma, biotech, research, and public-sector roles. |
| Geographic targeting potential | High | Singapore location supports regional and global targeting across APAC and international research networks. |
| Best outreach approach | Direct, value-based, clinical and research-focused | Lead with outcomes, evidence, compliance, and care-impact messaging. |
| Overall lead quality | High | A focused niche conference with meaningful decision-maker and influencer density. |
| Best use case | B2B attendee profiling, healthcare lead generation, research partnerships, and sponsored outreach | Useful for prospecting into hospitals, pharma, biotech, research, and public-health organizations. |
| Limitations / risks | Moderate data limitation | Confirmed participant lists were not fully public in the supplied source text; some company entries are market-fit targets rather than confirmed attendees. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Research; Information Technology & Services; Government Administration; Nonprofit Organization Management; Higher Education; Health, Wellness & Fitness | Match the event’s clinical, research, public-sector, and technology audience. |
| Departments | Clinical; Research; Procurement; Operations; Partnerships; IT; Public Health | Capture both decision-makers and program influencers. |
| Seniority | Manager; Director; VP; Head; C-Level; Senior Researcher | Prioritize budget holders and strategic influencers. |
| Job titles | Medical Director, Director of Neurology, Geriatrics Lead, Research Director, Principal Investigator, Clinical Trials Manager, Procurement Manager, Program Director, Operations Director, Digital Health Lead, Partnerships Director | Align outreach to the most likely buying or influencing roles. |
| Geography | Singapore; Southeast Asia; APAC; Global research hubs | Prioritize local and regional healthcare ecosystems while retaining global reach. |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,000+ | Covers specialist clinics, mid-market providers, and enterprise health systems. |
| Keywords | dementia, Alzheimer’s, neurology, geriatrics, cognitive health, neurodegenerative, memory clinic, clinical research, neuropharmacology, aged care | Find event-relevant contacts and organizations. |
| Company type | Hospitals, research institutes, pharma, biotech, nonprofits, public agencies, universities | Focus on buyer-side and influence-side organizations. |
Suggested Apollo Search Logic: ("dementia" OR "Alzheimer*" OR neurology OR geriatrics OR "neurodegenerative" OR "memory clinic" OR "clinical research") AND (director OR head OR manager OR VP OR chief OR lead)
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Dementia World Conference official website | Official organizer event site | Event name, dates, venue, Singapore location, hybrid format, theme, speaker highlights, and visitor statement | High |
| Official website page content captured in prompt | Primary source text | Organizer identity (Precision Global Conferences), scientific sessions, featured speakers, early-bird deadlines, and attendance statement | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 3rd Edition of Dementia World Conference DWC 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds